These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 474008)

  • 1. [Yeast NaRNA as a stimulator of the virulence, immunogenicity and antigenicity of salmonellae].
    Zemskov AM
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Jul; (7):72-6. PubMed ID: 474008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors of Salmonella typhi virulence in relation to the development of new vaccines].
    García JA; Paniagua J; Pelayo R; Isibasi A; Kumate J
    Salud Publica Mex; 1992; 34(3):262-7. PubMed ID: 1615345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stimulation of primary and secondary immune responses with yeast NaRNA].
    Zemskov AM
    Mikrobiol Zh (1978); 1980; 42(2):219-25. PubMed ID: 7382867
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.
    Tacket CO; Ferreccio C; Robbins JB; Tsai CM; Schulz D; Cadoz M; Goudeau A; Levine MM
    J Infect Dis; 1986 Aug; 154(2):342-5. PubMed ID: 2425009
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of gastric mucin and commercial baker's yeast as virulence-enhancing agents in the typhoid mouse protection test.
    Joó I; Zsidai J
    J Biol Stand; 1982 Jan; 10(1):17-24. PubMed ID: 6175648
    [No Abstract]   [Full Text] [Related]  

  • 6. A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans.
    Hone DM; Attridge SR; Forrest B; Morona R; Daniels D; LaBrooy JT; Bartholomeusz RC; Shearman DJ; Hackett J
    Infect Immun; 1988 May; 56(5):1326-33. PubMed ID: 3356467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectivity and antigenicity of streptomycin-dependent Salmonella typhosa.
    Reitman M
    J Infect Dis; 1967 Feb; 117(1):101-7. PubMed ID: 4165395
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).
    Tramont EC; Chung R; Berman S; Keren D; Kapfer C; Formal SB
    J Infect Dis; 1984 Feb; 149(2):133-6. PubMed ID: 6366077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Salmonella vaccines.
    Svenson SB; Lindberg AA
    Prog Allergy; 1983; 33():120-43. PubMed ID: 6187015
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant live Salmonella spp. for human vaccination against heterologous pathogens.
    Bumann D; Hueck C; Aebischer T; Meyer TF
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):357-64. PubMed ID: 10727892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers.
    DiPetrillo MD; Tibbetts T; Kleanthous H; Killeen KP; Hohmann EL
    Vaccine; 1999 Oct; 18(5-6):449-59. PubMed ID: 10519934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens.
    Cervantes-Barragán L; Gil-Cruz C; Pastelin-Palacios R; Lang KS; Isibasi A; Ludewig B; López-Macías C
    Eur J Immunol; 2009 Jan; 39(1):126-35. PubMed ID: 19130558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with Salmonella typhi Vi capsular polysaccharide vaccine.
    Hessel L; Debois H; Fletcher M; Dumas R
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):609-20. PubMed ID: 10534182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
    Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
    Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of Vi antigens from Salmonella typhi: implications for virulence and diagnosis.
    Tsang RS; Wong A
    FEMS Microbiol Immunol; 1989 Dec; 1(8-9):437-41. PubMed ID: 2627498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Vi Negative Isolates of Salmonella Enterica Serovar Typhi.
    Haque A
    Adv Exp Med Biol; 2018; 1052():9-18. PubMed ID: 29785477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the response to the enterobacterial common antigen after typhoid vaccination.
    Milhomem AM; Suassuna I
    Rev Soc Bras Med Trop; 1987; 20(1):7-12. PubMed ID: 3507980
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenic interrelationship between Salmonella typhi and Salmonella paratyphi A.
    Mates A; Bukovsky E
    Z Immunitatsforsch Exp Klin Immunol; 1973 Nov; 146(2):136-44. PubMed ID: 4282971
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans.
    Forrest BD; LaBrooy JT
    Vaccine; 1991 Jul; 9(7):515-20. PubMed ID: 1716810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant heat shock protein 60 (Hsp60/GroEL) of Salmonella enterica serovar Typhi elicits cross-protection against multiple bacterial pathogens in mice.
    Chitradevi ST; Kaur G; Singh K; Sugadev R; Bansal A
    Vaccine; 2013 Apr; 31(16):2035-41. PubMed ID: 23474314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.